Order Article Reprints

Wong YP, Wagiman N, Tan JWD, Hanim BS, Rashidan MSH, Fong KM, Norhazli NN, Qrisha Y, Shah RNRA, Mustangin M, et al. Loss of CXC-Chemokine Receptor 1 Expression in Chorioamnionitis Is Associated with Adverse Perinatal Outcomes. Diagnostics. 2022; 12(4):882. https://doi.org/10.3390/diagnostics12040882

Wong, Yin Ping, Noorhafizah Wagiman, Jonathan Wei De Tan, Barizah Syahirah Hanim, Muhammad Syamil Hilman Rashidan, Kai Mun Fong, Naufal Naqib Norhazli, Yashini Qrisha, Raja Norazah Raja Alam Shah, Muaatamarulain Mustangin, and et al. 2022. "Loss of CXC-Chemokine Receptor 1 Expression in Chorioamnionitis Is Associated with Adverse Perinatal Outcomes" Diagnostics 12, no. 4: 882. https://doi.org/10.3390/diagnostics12040882

Wong, Y. P., Wagiman, N., Tan, J. W. D., Hanim, B. S., Rashidan, M. S. H., Fong, K. M., Norhazli, N. N., Qrisha, Y., Shah, R. N. R. A., Mustangin, M., Zakaria, H., Chin, S. X., & Tan, G. C. (2022). Loss of CXC-Chemokine Receptor 1 Expression in Chorioamnionitis Is Associated with Adverse Perinatal Outcomes. Diagnostics, 12(4), 882. https://doi.org/10.3390/diagnostics12040882